Globe Life (NYSE:GL – Free Report) had its target price raised by JPMorgan Chase & Co. from $180.00 to $181.00 in a research note released on Thursday morning,Benzinga reports. They currently have an overweight rating on the stock.
Other equities analysts also recently issued research reports about the company. Truist Financial raised their target price on Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a research report on Friday, October 24th. Piper Sandler reissued an “overweight” rating and set a $167.00 price objective on shares of Globe Life in a report on Friday, November 21st. Weiss Ratings downgraded shares of Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, January 14th. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Finally, Wells Fargo & Company reduced their price target on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $171.00.
View Our Latest Research Report on Globe Life
Globe Life Price Performance
Globe Life (NYSE:GL – Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, research analysts expect that Globe Life will post 13.87 EPS for the current fiscal year.
Insider Buying and Selling at Globe Life
In other news, CEO Frank M. Svoboda sold 9,379 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the transaction, the chief executive officer directly owned 35,868 shares in the company, valued at approximately $5,036,943.24. This represents a 20.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.51% of the company’s stock.
Institutional Investors Weigh In On Globe Life
Several institutional investors have recently modified their holdings of GL. Norges Bank bought a new position in Globe Life in the second quarter valued at approximately $157,722,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of Globe Life by 34,786.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock worth $123,345,000 after purchasing an additional 879,391 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Globe Life by 98.6% in the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after purchasing an additional 696,548 shares during the last quarter. Balyasny Asset Management L.P. bought a new stake in Globe Life in the third quarter valued at about $80,925,000. Finally, Leith Wheeler Investment Counsel Ltd. increased its holdings in Globe Life by 615.9% in the second quarter. Leith Wheeler Investment Counsel Ltd. now owns 656,807 shares of the company’s stock valued at $81,635,000 after purchasing an additional 565,061 shares during the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
See Also
- Five stocks we like better than Globe Life
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- Trump’s AI Secret: 100X Faster Than Nvidia
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
